KANTARO
LIVE

Serial Number

88922047

Owner

Kantaro Biosciences LLC

Attorney

Michelle A. Cooke

First Use Date

Aug 14, 2020

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KANTARO Trademark

Serial Number: 88922047 • Registration: 6680233

KANTARO is a trademark filed by Kantaro Biosciences LLC on May 18, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Kantaro Biosciences LLC (13 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 16

Trademark Details

Filing Date

May 18, 2020

Registration Date

March 22, 2022

First Use Anywhere

August 14, 2020

First Use in Commerce

August 28, 2020

Published for Opposition

July 27, 2021

Goods & Services

Medical, pharmaceutical, scientific and clinical research and analysis; Medical and scientific research in the fields of viral and infectious diseases; Design and development of medical diagnostic test kits; Research, analysis, design and development services relating to apparatus, instruments, devices and equipment for medical diagnostics and testing, medical diagnostic tests, and technical consultancy services relating to the foregoing; Providing medical testing services and information in the field of medical and viral and infectious diseases research; Development of scientific research and technology for purposes of disease testing, diagnosis, testing, monitoring, prevention, treatment and health maintenance; Conducting clinical trials for others relating to medical and pharmaceutical products; Research and development of pharmaceuticals for the treatment of infections, viruses, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological and autoimmune diseases and disorders; Providing a website featuring medical research information, pharmaceutical research information, scientific research information and clinical research information about medical devices, diagnostics, research, analysis, monitoring and treatment of infections, viruses and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical, scientific and clinical research regarding development of vaccines and medicines

Filing History

REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 12, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 11, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 28, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2022 AITU
USE AMENDMENT FILED
Jan 13, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 13, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 21, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP